natgillin/translations-raw huggingface dataset:
Da Leflunomide medac er et generisk lægemiddel, som er bioækvivalent med referencelægemidlet, anses benefit/risk-forholdet for at være det samme som for referencelægemidlet.
Because Leflunomide medac is a generic medicine and is bioequivalent to the reference medicine, its benefit and risk are taken as being the same as the reference medicine’s.
Da Leflunomide ratiopharm er et generisk lægemiddel, som er bioækvivalent med referencelægemidlet, anses benefit/risk-forholdet for at være det samme som for referencelægemidlet.
Because Leflunomide ratiopharm is a generic medicine and is bioequivalent to the reference medicine, its benefit and risk are taken as being the same as the reference medicine’s.
Da lenalidomid har antineoplastisk aktivitet, kan der optræde komplikationer i form af tumorlysesyndrom (TLS).
Because lenalidomide has anti-neoplastic activity the complications of tumour lysis syndrome(TLS) may occur.
Da Leucofeligen FeLV/RCP fremstilles af to vacciner, som har været på markedet i Den Europæiske Union siden 1980’erne (Feligen RCP og Leucogen), fremlagde virksomheden oplysninger fra undersøgelser med disse vacciner til at understøtte brugen af Leucofeligen FeLV/RCP.
Because Leucofeligen FeLV/RCP is made up of two vaccines that have been available in the European Union (EU) since the 1980s (Feligen RCP and Leucogen), the company used data from studies carried out with these vaccines to support the use of Leucofeligen FeLV/RCP.
Da leverdysfunktion (forhøjede transaminase- og bilirubinværdier) kan forekomme (især efter doser på over 1.000 mg/m2 dexrazoxan), anbefales det, at leverfunktionstest skal udføres regelmæssigt før hver administration af dexrazoxan til patienter, hos hvem der er kendskab til leverfunktionsforstyrrelser.
Since liver dysfunction (increases in transaminases and bilirubin) may occur (especially after doses of above 1 000 mg/m2 dexrazoxane), it is recommended that routine liver function tests be performed before each administration of dexrazoxane in patients with known liver function disorders.
Da Levetiracetam Actavis Group er et generisk lægemiddel, som er bioækvivalent med referencelægemidlet, anses benefit/risk-forholdet for at være det samme som for referencelægemidlet.
Because Levetiracetam Actavis Group is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Da Levetiracetam Hospira er et generisk lægemiddel, som er bioækvivalent med referencelægemidlet, anses benefit/risk-forholdet for at være det samme som for referencelægemidlet.
Because Levetiracetam Hospira is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Da Levetiracetam Sun er et generisk lægemiddel, som er bioækvivalent med referencelægemidlet, anses benefit/risk-forholdet for at være det samme som for referencelægemidlet.
Because Levetiracetam Sun is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Da Levetiracetam Teva er et generisk lægemiddel, som er bioækvivalent med referencelægemidlet, anses benefit/risk-forholdet for at være det samme som for referencelægemidlet.
Because Levetiracetam Teva is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Da lithium øger frigivelsen af neutrofiler, er det muligt, at lithium forstærker effekten af filgrastim.
Since lithium promotes the release of neutrophils, lithium is likely to potentiate the effect of filgrastim.
Da Lojuxta kan påvirke virkningen af andre lægemidler og andre lægemidler kan påvirke Lojuxta, vil lægen eventuelt ændre tidspunktet for indtagelse af din medicin.
Because of the possibility of interactions with other medications, your doctor may change the time of day you take your medications.
Da lopinavirs og ritonavirs renale clearance er forsvindende lille, forventes det ikke, at patienter med nedsat nyrefunktion vil have forhøjede plasmakoncentrationer.
Since the renal clearance of lopinavir and ritonavir is negligible, increased plasma concentrations are not expected in patients with renal impairment.
Da lopper og flåter skal begynde at suge næring fra hunden for at blive dræbt af lægemidlet, kan det ikke udelukkes, at de kan overføre sygdomme, som de er inficeret med.
Because fleas and ticks must start feeding on the dog in order to be killed by the medicine, the risk of transmission of diseases with which they may be infected cannot be excluded.
Da lopper og flåter skal begynde at suge næring fra hunden for at blive dræbt af medicinen, kan de stadig overføre sygdomme, som de kan være inficeret med.
Because fleas and ticks must start feeding on the dog in order to be killed by the medicine, they might still be able to transmit any diseases with which they may be infected.
Da lopper og flåter skal begynde at suge næring fra hunden for at blive dræbt af medicinen, kan det ikke udelukkes, at de kan overføre sygdomme, som de er inficeret med.
Because fleas and ticks must start feeding on the dog in order to be killed by the medicine, the risk of transmission of diseases with which they may be infected cannot be excluded.
Da lopper og flåter skal begynde at suge næring fra hunden for at blive dræbt af medicinen, kan det ikke udelukkes, at de kan overføre sygdomme, som de kan være inficeret med.
Because fleas and ticks must start feeding on the dog in order to be killed by the medicine, the risk of transmission of diseases with which they may be infected cannot be excluded.
Da Loxicom er et generisk lægemiddel, har undersøgelserne bestået i at påvise, at det er bioækvivalent med referencelægemidlet Metacam.
Since Loxicom is a generic medicine, studies have been conducted to determine that it is bioequivalent to the reference medicine, Metacam.
Da lægemidlet imidlertid har en ny virkningsmåde, få bivirkninger og en anderledes sikkerhedsprofil end de eksisterende antidepressive lægemidler, konkluderede udvalget, at Valdoxan kan være en god behandling for nogle patienter, når blot deres leverfunktion bliver kontrolleret hyppigt.
However, since the medicine has a different mode of action, few side effects and a different safety profile to existing antidepressants, the Committee concluded that Valdoxan could be a valuable treatment for some patients as long as their liver function is tested frequently.
Da lægemidlet kan findes i sæd, må lægemidlet heller ikke anvendes til mandlige patienter, der ikke kan overholde de nødvendige kontraceptive foranstaltninger.
As the medicine can be found in semen, the medicine must also not be used in male patients who are unable to comply with the required contraceptive measures.
Da lægemidlet vil blive anvendt under din knækirurgi, har hospitalspersonalet ansvaret for den korrekte opbevaring af lægemidlet både før og under dets anvendelse og for en korrekt bortskaffelse.
Since this product will be used during your knee surgery, the hospital staff is responsible for the correct storage of the product both before and during its use, as well as for the correct disposal
Da lægemidlets sikkerhed hos hanhunde anvendt til avl ikke er fastlagt, må det kun anvendes i overensstemmelse med den ansvarlige dyrlæges vurdering af benefit/risk-forholdet.
As the safety of this veterinary medicinal product in male dogs used for breeding has not been determined, it should only be used according to the benefit-risk assessment by the responsible veterinarian
Da MACI imidlertid implanteres i forbindelse med invasive kirurgiske teknikker, anbefales det ikke under graviditet.
However as MACI will be implanted using invasive surgical techniques, it is not recommended during pregnancy.
Da MACI imidlertid implanteres i forbindelse med invasive kirurgiske teknikker, skal der træffes beslutning om, hvorvidt amning skal afbrydes under hensyn til de behandlingsmæssige fordele for kvinden og risikoen for spædbarnet.
However as MACI will be implanted using invasive surgical techniques, a decision must be made whether to discontinue breast- feeding taking into account the benefits of treatment for the woman and the risk to the infant.
Da MACI implanteres i forbindelse med kirurgi, påvirker implantation i væsentlig grad evnen til at føre motorkøretøj og betjene maskiner.
Due to the surgical nature of the underlying procedure, implantation with MACI has a major influence on the ability to drive and use machines.
Da man i studier med dyr med høje doser har konstateret, at både nyrerne og leveren er målorganer for toksiciteten, bør nyre- og leverfunktion overvåges.
Since both the kidney and the liver were found to be target organs for toxicity in preclinical studies with high doses, kidney and liver function should be monitored.
Da mange stoffer udskilles i modermælken, bør ammende kvinder ophøre med Vistide eller stoppe amningen, hvis de fortsætter med Vistide.
Because many medicines are passed through to human milk, nursing mothers should stop Vistide or stop breast-feeding if they continue to receive Vistide.
Da Marixino er et generisk lægemiddel, som er bioækvivalent med referencelægemidlet, anses benefit/risk-forholdet for at være det samme som for referencelægemidlet.
Because Marixino is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Da maropitant akkumuleres i kroppen under en 14-dages behandlingsperiode på grund af en metabolisk mætning, bør der ved langtidsbehandling iværksættes omhyggelig overvågning af leverfunktionen og bivirkninger.
As maropitant is accumulated in the body during a 14 day treatment period due to metabolic saturation, careful monitoring of liver function and any adverse events should be implemented during long term treatment.
Da maropitant akkumuleres i kroppen under en 14-dages behandlingsperiode på grund af en metabolisk mætning, bør der ved langtidsbehandling iværksættes omhyggelig overvågning af leverfunktionen og bivirkninger.
As maropitant is accumulated in the body during a 14 day treatment period due to metabolic saturation, careful monitoring of liver function in addition to any adverse events should be implemented during long term treatment.
Da maropitant akkumuleres i kroppen under en 14-dages behandlingsperiode på grund af en metabolisk mætning, bør der ved langtidsbehandling iværksættes omhyggelig overvågning af leverfunktionen og bivirkninger.
As maropitant is accumulated in the body during a 14 day treatment period due to metabolic saturation, careful monitoring of liver function should be implemented during long term treatment.
Da Memantine Accord er et generisk lægemiddel og er bioækvivalent med referencelægemidlet, antages det at have de samme fordele og risici som referencelægemidlet.
Because Memantine Accord is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Da Memantine LEK er et generisk lægemiddel, som er bioækvivalent med referencelægemidlet, anses benefit/risk-forholdet for at være det samme som for referencelægemidlet.
Because Memantine LEK is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Da Memantine Mylan er et generisk lægemiddel, som er bioækvivalent med referencelægemidlet, anses benefit/risk-forholdet for at være det samme som for referencelægemidlet.
Because Memantine Mylan is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Da Memantine ratiopharm er et generisk lægemiddel, som er bioækvivalent med referencelægemidlet, anses benefit/risk-forholdet for at være det samme som for referencelægemidlet.
Because Memantine ratiopharm is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Da mere end én infusionsrelateret reaktion kan være opstået under en enkelt infusion, er ovenstående tal sandsynligvis en overvurdering af den faktiske forekomst af infusionsrelaterede reaktioner.
Since more than one infusion-related reaction may have occurred during any single infusion, the above numbers are likely to over estimate the true incidence of infusion reactions.
Da metabolisering og udskillelse af doxorubicin primært sker ad hepatobiliær vej, bør der gennemføres en vurdering af den hepatobiliære funktion før og under behandling med Myocet.
As metabolism and excretion of doxorubicin occurs primarily by the hepatobiliary route, evaluation of hepatobiliary function should be performed before and during therapy with Myocet.
Da metformin udskilles af nyrerne, skal koncentrationen af serum-kreatinin bestemmes regelmæssigt:
As metformin is excreted by the kidney, serum creatinine concentrations should be determined regularly:
Da metformin udskilles af nyrerne, skal kreatininkoncentrationerne i serum monitoreres regelmæssigt:
As metformin is excreted by the kidney, serum creatinine concentrations should be monitored regularly:
Da metformin udskilles via nyrerne bør serum-kreatininkoncentrationen bestemmes regelmæssigt:
As metformin is excreted by the kidney, serum creatinine concentrations should be determined regularly:
Da metformin udskilles via nyrerne, bør serum-kreatininkoncentrationen bestemmes regelmæssigt:
As metformin is excreted by the kidney, serum creatinine concentrations should be determined regularly:
Da MPAG-plasmakoncentrationer forhøjes ved nedsat nyrefunktion, lige som aciclovir-koncentrationerne bliver det, er der en mulighed for, at mycophenolatmofetil og aciclovir, eller dets prodrugs, f.eks. valaciclovir, vil konkurrere om den renale tubulære sekretion, og at der kan ske yderligere forhøjelser af koncentrationerne af begge stoffer.
Because MPAG plasma concentrations are increased in the presence of renal impairment, as are aciclovir concentrations, the potential exists for mycophenolate mofetil and aciclovir, or its prodrugs, e.g. valaciclovir, to compete for tubular secretion and further increases in concentrations of both substances may occur.
Da MPAG-plasmakoncentrationer forhøjes ved nedsat nyrefunktion, ligesom aciclovir-koncentrationerne bliver det, er der en mulighed for, at mycophenolatmofetil og aciclovir, eller dets prodrugs, f.eks. valaciclovir, vil konkurrere om den tubulære sekretion, og at der kan ske yderligere forhøjelser af koncentrationerne af begge stoffer.
Because MPAG plasma concentrations are increased in the presence of renal impairment, as are aciclovir concentrations, the potential exists for mycophenolate mofetil and aciclovir, or its prodrugs, e.g. valaciclovir, to compete for tubular secretion and further increases in concentrations of both substances may occur.
Da mTOR er medvirkende til at kontrollere cellernes deling og blodkarrenes vækst, forhindrer Afinitor tumorcellernes deling og reducerer deres blodforsyning.
Since mTOR is involved in the control of cell division and the growth of blood vessels, Afinitor prevents the division of tumour cells and reduces their blood supply.
Da mTOR medvirker til at kontrollere celledeling, forebygger Torisel delingen af kræftceller, hvilket får kræften til at vokse og sprede sig langsommere.
Since mTOR is involved in the control of cell division, Torisel prevents the division of cancer cells, slowing down the growth and spread of the cancer.
Da muligheden for interaktioner imidlertid ikke helt kan udelukkes, bør samtidig administrering af kendte CYP3A4 inhibitorer (f.eks. erythromycin, itaconazol, ketoconazol og diltiazem) til patienter med udbredte og/eller erythrodermiske lidelser ske med forsigtighed.
However, the possibility of interactions cannot be ruled out and the concomitant systemic administration of known CYP3A4 inhibitors (e.g. erythromycin, itraconazole, ketoconazole and diltiazem) in patients with widespread and/or erythrodermic disease should be done with caution.
Da muligheden for øget risiko for udvikling af cancer hos patienter med nydiagnosticeret dysplasi behandlet med infliximab ikke er klarlagt, skal risiko og gavn for de individuelle patienter nøje vurderes og eventuel afbrydelse af behandlingen tages i betragtning.
Since the possibility of increased risk of cancer development in patients with newly diagnosed dysplasia treated with infliximab is not established, the risk and benefits to the individual patients must be carefully reviewed and consideration should be given to discontinuation of therapy.
Da muligheden for øget risiko for udvikling af cancer hos patienter med nydiagnosticeret dysplasi behandlet med infliximab ikke er vist, skal risiko og gavn for de individuelle patienter nøje vurderes og eventuel afbrydelse af behandlingen tages i betragtning.
Since the possibility of increased risk of cancer development in patients with newly diagnosed dysplasia treated with infliximab is not established, the risk and benefits to the individual patients must be carefully reviewed and consideration should be given to discontinuation of therapy.
Da muligheden for øget risiko for udvikling af cancer hos patienter med nydiagnosticeret dysplasi behandlet med Remicade ikke er vist, skal risiko og gavn for de individuelle patienter nøje vurderes og eventuel afbrydelse af behandlingen tages i betragtning.
Since the possibility of increased risk of cancer development in patients with newly diagnosed dysplasia treated with Remicade is not established, the risk and benefits to the individual patients must be carefully reviewed and consideration should be given to discontinuation of therapy.
Da MULTAQ-informationskortet og tjeklisten for læger ikke indeholder alle advarsler og kontraindikationer, skal der henvises til SmPC for MULTAQ, før MULTAQ udskrives og før udskrivning af andre lægemidler til patienter, der får MULTAQ.
As the MULTAQ Information Card and the Prescriber check list do not include all warnings or contraindications, the SmPC should be referred to prior to prescribing MULTAQ and also prior to prescribing additional medicinal products to a patient already taking MULTAQ.
Da Mycophenolate mofetil Teva er et generisk lægemiddel, som er bioækvivalent med referencelægemidlet, anses benefit/risk-forholdet for at være det samme som for referencelægemidlet.
Because Mycophenolate mofetil Teva is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Da mycophenolatmofetil har udvist fosterbeskadigende virkning hos rotter og kaniner, må CellCept tabletter ikke knuses.
Because mycophenolate mofetil has demonstrated teratogenic effects in rats and rabbits, CellCept tablets should not be crushed.
Da mycophenolatmofetil har udvist fosterbeskadigende virkning hos rotter og kaniner, må Myclausen tabletter ikke knuses.
Because mycophenolate mofetil has demonstrated teratogenic effects in rats and rabbits, Myclausen film-coated tablets should not be broken or crushed.
Da mycophenolatmofetil har udvist fosterbeskadigende virkning hos rotter og kaniner, skal inhalation undgås og undgå, at hud og slimhinder kommer i direkte kontakt med det tørre pulver og undgå, at hud kommer i direkte kontakt med den rekonstituerede suspension.
Because mycophenolate mofetil has demonstrated teratogenic effects in rats and rabbits, avoid inhalation or direct contact with skin or mucous membranes of the dry powder as well as direct contact of the reconstituted suspension with the skin.
Da mycophenolatmofetil har udvist teratogen virkning hos rotter og kaniner, må Mycophenolate mofetil Teva kapsler ikke åbnes eller knuses for at undgå inhalation og undgå at hud og slimhinder kommer i direkte kontakt med pulveret i Mycophenolate mofetil Teva kapslerne.
Because mycophenolate mofetil has demonstrated teratogenic effects in rats and rabbits, Mycophenolate mofetil Teva capsules should not be opened or crushed to avoid inhalation or direct contact with skin or mucous membranes of the powder contained in Mycophenolate mofetil Teva capsules.
Da mycophenolatmofetil har udvist teratogen virkning hos rotter og kaniner, må Myfenax kapsler ikke åbnes eller knuses for at undgå inhalation og undgå at hud og slimhinder kommer i direkte kontakt med pulveret i Myfenax kapslerne.
Because mycophenolate mofetil has demonstrated teratogenic effects in rats and rabbits, Myfenax capsules should not be opened or crushed to avoid inhalation or direct contact with skin or mucous membranes of the powder contained in Myfenax capsules.
Da mycophenolatmofetil har udvist teratogen virkning hos rotter og kaniner, må Myfenax tabletter ikke knuses.
Because mycophenolate mofetil has demonstrated teratogenic effects in rats and rabbits, Myfenax tablets should not be crushed.
Da mycophenolatmofetil har udvist teratogen virkning hos rotter og kaniner, skal det undgås, at hud og slimhinder kommer i direkte kontakt med tørt pulver og opløsninger af CellCept 500 mg pulver til koncentrat til infusionsvæske undgås.
Because mycophenolate mofetil has demonstrated teratogenic effects in rats and rabbits, avoid direct contact of the dry powder or prepared solutions of CellCept 500 mg powder for concentrate for solution for infusion with skin or mucous membranes.
Da Myfenax er et generisk lægemiddel, som er bioækvivalent med referencelægemidlet, anses benefit/risk-forholdet for at være det samme som for referencelægemidlet.
Because Myfenax is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Da myokarditis desuden er en potentielt livstruende hændelse, der kan fejldiagnosticeres, anbefalede PRAC at opdatere den nuværende advarsel vedr. reduktion af venstre ventrikels ejektionsfraktion (LVEF)/dysfunktion af venstre ventrikel for at inkludere en specifik reference til disse tilfælde af myokarditis for at gøre ordinerende læger opmærksom på risikoen for denne bivirkning samt fremhæve, at seponering af behandlingen medfører ophør af myokarditis.
In addition, in the context of myocarditis being a potentially life-threatening event that can be misdiagnosed, the PRAC recommended that the existing warning on left ventricular ejection fraction (LVEF) reduction/Left ventricular dysfunction should be updated to include specific reference to these cases of myocarditis in order to raise awareness of the possibility of this adverse reaction amongst prescribers, and highlight that stopping treatment resolved the myocarditis.
Da mængden af natrium i den maksimale daglige dosis kan overstige 200 mg, kan det være skadeligt for personer på lav natriumdiæt.
As the quantity of sodium in the maximum daily dose may exceed 200 mg, this should be taken into consideration by patients on a controlled sodium diet.
Da nedsatte koncentrationer af artemether, dihydroartemisinin eller lumefantrin kan føre til en nedsat virkning mod malaria, bør der udvises forsigtighed, når Atripla og artemether/ lumefantrin-tabletter administreres samtidigt.
Since decreased concentrations of artemether, dihydroartemisinin, or lumefantrine may result in a decrease of antimalarial efficacy, caution is recommended when Atripla and artemether/lumefantrine tablets are co-administered.
Da nelfinavir er kraftigt proteinbundet er det ikke sandsynligt, at dialyse kan fjerne det fra blodet i væsentlig grad.
Since nelfinavir is highly protein bound, dialysis is unlikely to significantly remove it from blood.
Da Nemdatine er et generisk lægemiddel, som er bioækvivalent med referencelægemidlet, anses benefit/risk-forholdet for at være det samme som for referencelægemidlet.
Because Nemdatine is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine’s.
Da Nevanac indeholder benzalkoniumchlorid, er tæt overvågning påkrævet ved hyppig eller langvarig anvendelse.
Since NEVANAC contains benzalkonium chloride, close monitoring is required with frequent or prolonged use.